Next Article in Journal
CT-Based Preplanning Allows Abstaining from Intraprocedural TEE during Interventional Closure of the LAA in Patients with Atrial Fibrillation
Previous Article in Journal
Reply to Mistry et al. The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on “Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11, 5158”
 
 
Editorial

Article Versions Notes

J. Clin. Med. 2023, 12(12), 4018; https://doi.org/10.3390/jcm12124018
Action Date Notes Link
article html file updated 13 June 2023 06:21 CEST Update https://www.mdpi.com/2077-0383/12/12/4018/html
article html file updated 13 June 2023 06:20 CEST Update -
article html file updated 13 June 2023 06:19 CEST Original file -
article pdf uploaded. 13 June 2023 06:18 CEST Version of Record https://www.mdpi.com/2077-0383/12/12/4018/pdf
article xml uploaded. 13 June 2023 06:18 CEST Update https://www.mdpi.com/2077-0383/12/12/4018/xml
article xml file uploaded 13 June 2023 06:18 CEST Original file -
Back to TopTop